Press Releases

MEXICO CITY--(BUSINESS WIRE)-- FIBRA Macquarie México (FIBRA Macquarie or the Trust) (BMV: FIBRAMQ) announced today by means of the publication of a call notice (the “Call Notice”) that it will convene an ordinary holders’ meeting (the “Meeting”) of holders of the real estate trust certificates identified with ticker “FIBRAMQ 12” (Certificados Bursátiles Fiduciarios Inmobiliarios or CBFIs), on June 10, 2024, at 11:00 am (Mexico City time) at the... (continue reading...)

Appia Rare Earths & Uranium (CSE: API) (OTCQX: APAAF) (FSE: A0I0), a publicly traded Canadian company in the rare earth element and uranium sectors, has announced the results from two of four new exploration targets located at the PCH Project. The results come from the Electra and Maia targets, which are in the central and midwestern portion grouping of claims. Highlights of the report indicate selected intercepts for heavy rare earth oxide (“HREO”), total rare... (continue reading...)

HIGHLIGHTS

• Sigma Lithium announces the loading of its ninth shipment, totaling 22,000 tonnes of its high purity Quintuple Zero Green lump lithium concentrate ("Quintuple Zero Green Lithium"), at the Port of Vitoria. The shipment was sold to LX International, formerly known as LG International.
• Sigma Lithium achieved a premium price calculated using a fixed-floating formula of 9% of lithium hydroxide quoted at LME. The price formula is final and non-provisional.... (continue reading...)

PHILADELPHIA, May 22, 2024 (GLOBE NEWSWIRE) -- Trial Equity and Miller Tanner Associates (MTA) are excited to announce a groundbreaking partnership aimed at expanding education and participation across diverse patient groups, in a strategic move to address the crucial gap in clinical trial diversity. This collaboration will co-market Trial Equity’s innovative Clinical Trial Diversity Training to pharmaceutical sponsors, CROs, and site networks, leveraging MTA's... (continue reading...)

PHILADELPHIA, May 22, 2024 (GLOBE NEWSWIRE) -- Trial Equity and Miller Tanner Associates (MTA) are excited to announce a groundbreaking partnership aimed at expanding education and participation across diverse patient groups, in a strategic move to address the crucial gap in clinical trial diversity. This collaboration will co-market Trial Equity’s innovative Clinical Trial Diversity Training to pharmaceutical sponsors, CROs, and site networks, leveraging MTA's... (continue reading...)